Pharmaclear PP Seal RP 62 EU introduces doubly effective counterfeit protection for pharmaceuticals
(UPM Raflatac, Tampere, 22 February 2016 at 11:00 EET) - UPM Raflatac has launched a new label face in EMEIA as part of a security range for prescription and high-risk over-the-counter pharmaceuticals. The destructible Pharmaclear PP Seal adds a second layer of security to the tamper-evident functionality of the RP 62 EU adhesive, by preventing label misappropriation on counterfeit products.
Pharmaclear PP Seal RP 62 EU is designed for use as a sealing label on cardboard packages with water-based varnishes. The RP 62 EU adhesive provides tamper-evidence by producing visible cardboard tear upon attempted removal, while the new Pharmaclear PP Seal label face visibly stretches, effectively destroying the label.
The label face and adhesive combination also supports compliance with the Falsified Medicines Directive (2011/62/EU) by incorporating tamper-evident features as described in the new CEN standard EN 16679: 'Packaging - Tamper verification features for medicinal product packaging'. This EU-delegated regulation on safety features is now published, with the deadline for meeting EN 16679 requirements set for 9 February 2019 in the majority of EU member states.
"Pharmaclear PP Seal strengthens our existing product range based on the RP 62 EU adhesive. The new product offers even wider features to better secure the supply chain, blends easily with existing package designs and branding, and fulfils the requirements of EN 16679 as the pharmaceutical industry seeks solutions ahead of the three-year deadline," comments Markku Pietarinen, Labelling Solutions Manager, Pharmaceutical labelling, UPM Raflatac EMEIA.
For further information please contact:
Markku Pietarinen, Labelling Solutions Manager, Pharmaceutical labelling, UPM Raflatac EMEIA, tel. +358 2041 6143
High resolution image can be downloaded at http://pet.upm.com/?cart=10407-elcddhgbji&l=EN
Learn more about our solutions for pharmaceutical and health care labelling at http://www.upmraflatac.com/emea/en/solutions-and-services/labeling-solutions/pharmaceutical-and-health-care
UPM Raflatac
UPM Raflatac is one of the world's leading producers of self-adhesive label materials. We supply high-quality paper and film label stock for consumer product and industrial labeling through a global network of factories, distribution terminals and sales offices. We employ around 2,800 people and made sales of EUR 1.2 billion (USD 1.5 billion) in 2014. UPM Raflatac is part of UPM - The Biofore Company. Find out more at www.upmraflatac.com.
Follow us on Twitter | LinkedIn | Facebook | YouTube
UPM
Through the renewing of the bio and forest industries, UPM is building a sustainable future across six business areas: UPM Biorefining, UPM Energy, UPM Raflatac, UPM Paper Asia, UPM Paper Europe and North America and UPM Plywood. Our products are made of renewable raw materials and are recyclable. We serve our customers worldwide. The group employs around 19,600 people and its annual sales are approximately EUR 10 billion. UPM shares are listed on NASDAQ OMX Helsinki. UPM - The Biofore Company - www.upm.com